Cannabis-Derived Ingredients in Cosmetic Products
Cannabis-derived ingredients are popular compounds with interesting properties. There is specific EU and national legislation regarding cannabis-derived ingredients, identifying which extracts and derivatives may be used in cosmetic products. There are several aspects to consider to ensure compliance when adding these compounds to cosmetics and personal care products.

CANNABIS PLANT AND CANNABIDIOL

Cannabidiol (CBD) is one of many different cannabinoids found and extracted from hemp (Cannabis sativa or Cannabis indica). Cannabidiol is normally located in the aerial parts of the plants (flowers, stems and leaves) and not in the roots or seeds. Although CBD is chemically similar to Tetrahydrocannabinol (THC), Cannabidiol does not cause a psychoactive effect (e.g. euphoric effects). Cannabigerol (CBG), another cannabinoid extracted from the plant, is a precursor molecule that can converted into other cannabinoids (like THC and CBD) during plant growth and is gaining more and more attention by consumers and the cosmetic industry.

EU LEGAL FRAMEWORK ON CANNABIS-DERIVED INGREDIENTS

In the European Union (EU) Cannabis sativa plant can be legally cultivated and supplied for industrial uses if the THC levels present in the plant do not surpass 0.2%.

According to Cosmetics Regulation (EC) No 1223/2009, there are several Cannabis-derivatives included in the list of substances prohibited in cosmetic products (Annex II) such as Cannabis and Cannabis resin (Cannabis sativa, ext.), Cannabis sativa flower extract, Cannabis sativa flower/stem extract or Cannabis sativa flower/leaf/stem extract. These substances cannot be used in cosmetic products under any circumstances. However, substances extracted from the seeds of Cannabis sativa, like Cannabis sativa seed oil and Cannabis sativa seed extract, among others, are allowed for use in cosmetic products if the THC level does not exceed 0.2% (THC is also included in Annex II).

Cannabidiol (CBD) is also included in the list of substances prohibited in cosmetic products (Annex II of the European Cosmetic Regulation). Its annex entry states that “Cannabidiol (CBD) as such, irrespective of its source, is not listed in the Schedules of the 1961 UN Single Convention on Narcotic Drugs. However, it shall be prohibited from use in cosmetic products (II/306) if it is prepared as an extract or tincture or resin of Cannabis in accordance with the Single Convention. Please note that national legislations on controlled substances may also apply.”.

This means that Cannabidiol may not be extracted from the flowers, fruits or resin because these parts have higher concentrations of THC. It can neither be prepared as an extract, tincture or resin. Cannabis seeds (when not accompanied with the fruiting tops) are not included in the list of banned ingredients of the Single Convention, so the use of Cannabidiol derived from seeds is not prohibited (again, THC levels cannot exceed 0.2%). Since CBD is mainly found in the aerial parts of the plants, the safest and most efficient way to legally use this substance in cosmetic products is by synthetic production.

Member States may have different regulations regarding Cannabis and its derivatives, which influence its use on cosmetic products. For example, France and Sweden have different restrictions for derivatives of Cannabis and its use on cosmetic products. On the other hand, Switzerland allows a maximum THC content of up to 1%.

CANNABIS IN THE U.S. COSMETIC PRODUCTS INDUSTRY

In the United States, the 2018 Farm Bill (Agriculture Improvement Act of 2018, Pub. L., 115-334) excluded Cannabis and cannabis-derived compounds with a THC concentration of no more than 0.3% (dry weight basis) from the Controlled Substances Act (CSA), which means that these compounds are no longer controlled substances under federal law. The U.S. Food and Drug Administration (FDA) is the authority that regulates products containing Cannabis and its derivatives. In the U.S., Cannabis and its derivatives (defined as hemp – Farm Bill 2018) are not cosmetic ingredients prohibited or restricted by regulation. Nevertheless, it must be taken into account that “a product is intended to affect the structure or function of the body, or diagnose, cure, mitigate, treat or prevent disease, it is a drug, or possibly both a cosmetic and a drug, even if it affects the appearance” in accordance with FDA regulations.

If a manufacturer would like to have Cannabidiol on its formulation and commercialize the product in the European Union, they should use Cannabidiol which is 100% chemically produced. Moreover, manufacturers must take into account the country of origin of the Cannabis-derived ingredients used and also the tolerance for THC content that has been set out at national level for industrial hemp.

In cosmetics, the Responsible Person plays a determinant role safeguarding the compliance of Cannabidiol-containing cosmetic products with regulations and closely monitoring its commercialization across the European Union. These products must not claim having therapeutic effects and should not confuse the public about its cannabis content.

If you need to place your CBD containing products in the EU market and need further information or guidance on this matter, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Single Convention on Narcotic Drugs, 1961. Available from: https://treaties.un.org/doc/Treaties/1964/12/19641213%2002-14%20AM/Ch_VI_15.pdf
  2. Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD). Available from:  https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd

further
reading

drug_device_combination_1
medical devices

Regulatory Framework of Drug-Device Combination

The advances in technology continue to merge different types of products and the historical lines of separation between medical devices and medicinal products are getting thinner. Products combining medicinal products and medical devices are regulated either by Regulation (EU) 2017/745 (MDR) or by Directive 2001/83/EC.

Read More »
cosmetic products

SCCS Preliminary Opinion on Alpha-Arbutin and Beta-Arbutin

Alpha-arbutin and Beta-arbutin are used in cosmetic with antioxidant, bleaching and skin conditioning functions. Following concerns raised during discussion within the Working Group on Cosmetic Products and consequent call for data on these ingredients, the SCCS assessed the safety of Alpha-arbutin and Beta-arbutin in cosmetic products.

Read More »
cosmetic products

Request for SCCS Scientific Opinion on Citral

The European Commission requested the SCCS to assess whether the derived safe use levels for Citral by the application of the QRA2 based on the induction of skin sensitization is adequate to protect consumers. A period of 9 months was set for issuing the scientific opinion.

Read More »
cosmetic products

SCCS Scientific Advice on the Safety of Triclocarban and Triclosan

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

Read More »
cosmetic products

Cosmetic Regulation in the Andean Community

In the Andean Community (Bolivia, Colombia, Ecuador and Peru), cosmetic products are mainly regulated by Decision 833. All cosmetic products made available in these countries must undergo a Mandatory Sanitary Notification (NSO) and need to be manufactured according to Good Manufacturing Practices (GMP).

Read More »
cosmetic products

Cosmetic Product Labelling in the European Union

The Regulation (EC) No 1223/2009 lays down the mandatory information that needs to be included in the packaging and container of a cosmetic products. In addition to this information, most cosmetic products include certain claims, which must be supported and properly substantiated.

Read More »
cosmetic products

Environmental Claims in the UK

Green claims are a trend among consumer goods and services. We often see claims like ‘clean beauty’, ‘environmental friendly’ and so many others. But how can companies ensure that these claims are not misleading? The UK’s Competition and Markets Authority (CMA) has published its Green Claims Code, in order to help companies comply with legal obligations when making environmental claims.

Read More »
cosmetic products

Parabens in Cosmetic Products

Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

Read More »
cosmetic products

The Product Information File (PIF)

A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.

Read More »